---
title: "NAGE.US (NAGE.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/NAGE.US/news.md"
symbol: "NAGE.US"
name: "NAGE.US"
parent: "https://longbridge.com/en/quote/NAGE.US.md"
datetime: "2026-03-04T13:08:55.895Z"
locales:
  - [en](https://longbridge.com/en/quote/NAGE.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/NAGE.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/NAGE.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/NAGE.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/NAGE.US/news.md)


# NAGE.US (NAGE.US) — Related News

### [BUZZ-Niagen Bioscience rises on U.S. patent for injectable NAD+ booster](https://longbridge.com/en/news/276900184.md)
*2026-02-25T14:10:29.000Z*
> Shares of Niagen Biosciencerose 3.3% to $5.28 in premarket trading after the company announced it secured a new U.S. pat

### [Niagen Bioscience Secures New U.S. Patent For Nicotinamide Riboside](https://longbridge.com/en/news/276896301.md)
*2026-02-25T13:41:23.000Z*
> Feb 25 (Reuters) - Niagen Bioscience Inc:* NIAGEN BIOSCIENCE INC - SECURES NEW U.S. PATENT FOR INTRAVENOUS AND INJECTION

### [Niagen Bioscience Secures New U.S. Patent Covering Intravenous and Injection Formulations and Methods of Use for Nicotinamide Riboside (NR), Niagen® | NAGE Stock News](https://longbridge.com/en/news/276896991.md)
*2026-02-25T05:32:00.000Z*
> Niagen Bioscience, Inc. (NASDAQ: NAGE) has secured a new U.S. Patent No. 12,558,367, enhancing its intellectual property

### [Niagen Bioscience is the Premiere Sponsor of the Inaugural “NAD for Health: Opportunities & Challenges” Conference Hosted by the University of Copenhagen | NAGE Stock News](https://longbridge.com/en/news/275325724.md)
*2026-02-09T05:34:00.000Z*
> Niagen Bioscience, Inc. (NASDAQ: NAGE) is the premiere sponsor of the inaugural "NAD for Health: Opportunities & Challen

### [Niagen Bioscience to Report Fourth Quarter and Full Year 2025 Financial Results on Wednesday, March 4, 2026 | NAGE Stock News](https://longbridge.com/en/news/275133431.md)
*2026-02-06T05:32:00.000Z*
> Niagen Bioscience, Inc. (NASDAQ: NAGE) will report its fourth quarter and full year 2025 financial results on March 4, 2